Figure 5

Correlation analysis of TJP1 and oncogenes in bladder cancer patients. (A) Frequency of genomic alteration in tumors from bladder cancer patients. *p < 0.05. (B) Major co-occurrences of genomic alterations of TJP1 and TTN, TP53 and RYR3 in bladder cancer patients. (C) Analysis of the correlation between TJP1 and TTN/TP53/RYR3 mRNA expression using TIMER. (D) STRING protein–protein interaction networks for TJP1, TP53, TTN and RYR3.